2137 — Brii Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Brii Biosciences, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,055	3,355	2,997	2,661	2,320
Net Total Receivables	—	51.5	57.7	71.1	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,093	3,414	3,077	2,783	2,414
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	43.9	33.4	19.5	5.61	14.3
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,268	3,612	3,392	3,198	2,707
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	575	281	229	126	77.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	3,006	269	197	79.2	49.7
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	-1,738	3,343	3,195	3,119	2,657
Total Liabilities & Shareholders' Equity	1,268	3,612	3,392	3,198	2,707
Total Common Shares Outstanding